Influence of a layer-by-layer-assembled multilayer of anti-CD34 antibody, vascular endothelial growth factor, and heparin on the endothelialization and anticoagulation of titanium surface

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 4, 2013, Pages 1144-1157

  Liu, Shihui ^a   Liu, Tao ^a   Chen, Junying ^a   Maitz, Manfred ^a,b   Chen, Cheng ^a   Huang, Nan ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

Author keywords

Anti CD34 antibody; Anticoagulation; Endothelialization; Heparin; Layer by layer assembly; Titanium

Indexed keywords

ANTI-CD34; ANTI-COAGULATION; ENDOTHELIALIZATION; HEPARIN; LAYER-BY-LAYER ASSEMBLIES;

ANTIBODIES; BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; MULTILAYERS; STENTS; TITANIUM;

POLYSACCHARIDES;

CD34 ANTIBODY; HEPARIN; TITANIUM; VASCULOTROPIN;

ACTIVATED BLOOD PLATELET; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; ATOM FORCE MICROSCOPY; BLOOD COMPATIBILITY; CELL ADHESION; CELL PROLIFERATION; CELLULAR PARAMETERS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIALIZATION; IMMOBILIZED CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LAYER BY LAYER SELF ASSEMBLY TECHNIQUE; MICROSCOPY; MOLECULAR INTERACTION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL VASCULAR SYSTEM; RAT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBORESISTANCE; WATER CONTACT ANGLE;

ANIMALS; ANTIBODIES; ANTIGENS, CD34; BLOOD COAGULATION; BLOOD PLATELETS; CELL ADHESION; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; FEMALE; GOATS; HEPARIN; HUMANS; MALE; MATERIALS TESTING; PARTIAL THROMBOPLASTIN TIME; PLATELET ADHESIVENESS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TITANIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876169051     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34392     Document Type: Article

References (47)

1. Hong J, Andersson J, Ekdahl KN, Elgue G, Axen N, Larsson R, Nilsson B. Titanium is a highly thrombogenic biomaterial: Possible implications for osteogenesis. Thromb Haemost 1999;82:58-64.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275: 964-967.
3. Calzi SL, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, Grant MB. EPCs and pathological angiogenesis: When good cells go bad. Microvasc Res 2010;79:207-216.
4. Avci-Adali M, Paul A, Ziemer G, Wendel HP. New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialization of blood contacting materials, Biomaterials 2008;29:3936-3945.
5. Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol 2003;92(6A):94L-95L.
6. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ. Endothelial progenitor cell capture by stents coated with antibody against anti-CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growthfirst in man) registry. J Am Coll Cardiol 2005;45:1574-1579.
7. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, Pasterkamp G. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005;112:12-18.
8. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009;4:62-72.
9. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 2009;15:180-189.
10. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
11. Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Mantovani D, Laroche G. Improving arterial prosthesis neo-endothelialization: Application of a proactive VEGF construct onto PTFE surfaces. Biomaterials 2005;26:7402-7409.
12. Pike DB, Cai SS, Pomraning KR, Firpo MA, Fisher RJ, Shu XZ, Prestwich GD, Peattie RA. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006;27:5242-5251.
13. Christensen K, Larsson R, Emanuelsson H, Elgue G, Larsson A. Heparin coating of the stent graft - Effects on platelets, coagulation and complement activation. Biomaterials 2001;22:349-355.
14. Gong F, Cheng X, Wang S, Zhao Y, Gao Y, Cai H. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomater 2010;6:534-546.
15. Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surg Res 2004;118:45-52.
16. Li QL, Huang N. Endothelial cell and platelet behavior on titanium modified with a mutilayer of polyelectrolytes. J Bioact Compat Polym 2009;24:129-150.
17. Meng S, Liu ZJ, Shen L, The effect of a layer-by-layer chitosanheparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009;30: 2276-2283.
18. Lu DL, Meng S, Zhong W, Du QG, Li G, Liu JF, Dusan B. Immobilization of biomacromolecules on poly-L-lactide surface via a layer-by-layer method for the improving of its cytocompatibility to bone marrow stromal cells. Chin Sci Bull 2005;50: 2809-2816.
19. Weng YJ. Surface Modification of Ti-O film by antithrombotic biomolecule immobilization and evaluation of its antithrombotic properties. Southwest Jiaotong University Doctor Degree Dissertation; 2004.
20. Chen C, Chen JY, Li QL, Chen JL, Tu QF, Chen SM, Liu SH, Huang N. The biological behavior of endothelial progenitor cells on titanium surface immobilized by anti-CD34 antibody. Adv Mater Res 2009;9-82:707-710.
21. Tokunaga Y, Yamazaki Y, Morita T. Localization of heparin-and neuropilin-1-recognition sites of viral VEGFs. Biochem Biophys Res Commun 2006;348:957-962.
22. Kujawa P, Schmauch G, Viitala T, Badia A, Winnik FM. Construction of viscoelastic biocompatible films via the layer-by-layer assembly of hyaluronan and phosphorylcholine-modified chitosan. Biomacromolecules 2007;8:3169-3176.
23. Lin Q, Ding X, Qiu F, Song X, Fu G, Ji J. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer. Biomaterials 2010;31: 4017-4025.
24. Cui X, Pei R, Wang Z, Yang F, Ma Y, Dong S, Yang X. Layer-bylayer assembly of multilayer films composed of avidin and biotinlabeled antibody for immunosensing. Biosen Bioelectron 2003;18: 59-67.
25. Li QL, Huang N, Chen C, Chen JL, Xiong KQ, Chen JY, You TX, Jin J, Liang X. Oriented immobilization of anti-CD34 antibody on titanium surface for self-endothelialization induction. J Biomed Mater Res A 2010;94:1283-1293.
26. Hou RX, Wu LG, Wang J, Huang N. Investigation on biological properties of tacrolimus-loaded poly(1,3-trimethylene carbonate) in vitro. Appl Surf Sci 2010;256:5000-5005.
27. Yang ZL, Wang J, Luo RF, Maitz MF, Jing F, Sun H, Huang N. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials 2010;31:2072-2083.
28. Chen JL, Li QL, Chen JY, Chen C, Huang N. Improving bloodcompatibility of titanium by coating collagen-heparin multilayers. Appl Surf Sci 2009;255:6894-6900.
29. Pradier CM, Salmain M, Zheng L, Jaouen G. Specific binding of avidin to biotin immobilised on modified gold surfaces Fourier transform infrared reflection absorption spectroscopy analysis. Surf Sci 2002;502-503:193-202.
30. Chung TW, Liu DZ, Wang SY, Wang SS. Enhancement of the growth of human endothelial cell by surface roughness at nanometer scale. Biomaterials 2003;24:4655-4661.
31. Oikawa Y, Minami T, Mayama H, Tsujii K, Fushimi K, Aoki Y, Skeldon P, Thompson GE, Habazaki H. Preparation of self-organized porous anodic niobium oxide microcones and their surface wettability. Acta Mater 2009;57:3941-3946.
32. Feng B, Weng J, Yang BC, Chen JY, Zhao JZ, He L, Qi SK, Zhang XD. Surface characterization of titanium and adsorption of bovine serum albumin. Mater Charact 2003;49:129-137.
33. Li GC, Zhang FM, Liao YZ, Yang P, Huang N. Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility. Colloid Surf B Biointerfaces 2010;81:255-262.
34. Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol 2010;55:1553-1562.
35. Parikh SA, Edelman ER. Endothelial cell delivery for cardiovascular therapy. Adv Drug Deliver Rev 2000;42:139-161.
36. Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003;24:2295-302.
37. Choudhary S, Haberstroh KM, Webster TJ. Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng 2007:1421-1430.
38. Ponsonnet L, Reybier K, Jaffrezic N, Comte V, Lagneau C, Lissac M, Martelet C. Relationship between surface properties (roughness, wettability) of titanium and titanium alloys and cell behaviour. Mater Sci Eng C 2003;23:551-560.
39. van Wachem PB, Vreriks CM, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG. The influence of protein adsorption on interactions of cultured human endothelial cells with polymers. J Biomed Mater Res A 1987;21:701-718.
40. Yin M, Yuan Y, Liu CS, Wang J. Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation. J Mater Sci Mater Med 2009;20: 1513-1523.
41. McSweeney PA, Rouleau KA, Wallace PM, Bruno B, Andrews RG, Krizanac-Bengez L, Sandmaier BM, Storb R, Wayner E, Nash RA. Characterization of monoclonal antibodies that recognize canine CD34. Blood 1998;91:1977-1986.
42. Butler JE, Ni L, Brown WR, Joshi KS, Chang J, Rosenberg B, Voss EW. The immunochemistry of sandwich ELISAs - VI. Greater than 90% of monoclonal and 75% of polyclonal anti-fluorescyl capture antibodies (CAbs) are denatured by passive adsorption. Mol Immunol 1993;30:1165-1175.
43. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
44. Adachi T, Matsushita T, Dong ZY, Katsumia A, Nakayamaa T, Kojimac T, Saitod H, Sadlerb JE, Naoea T. Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor. Biochem Biophys Res Commun 2006;339:1178-1183.
45. Blackburn MN, Smith RL, Carson J, Sibley CC. The heparinbinding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence. J Biol Chem 1984;259: 939-941.
46. Olson ST, Bjork I. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J Biol Chem 1991;26:6353-6364.
47. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992;267:12528-12538.